|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Performance of liver stiffness measurements by transient elastography in chronic hepatitis显示文摘AIM:To compare results of liver stiffness measurements by transient elastography(TE) obtained in our patients population with that used in a recently published meta-analysis.METHODS:This was a single center cross-sectional study.Consecutive patients with chronic viral hepatitis scheduled for liver biopsy at the outpatient ward of our Infectious Diseases Department were enrolled.TE was carried out by using FibroScan(Echosens,Paris,France).Liver biopsy was performed on the same day as TE,as day case procedure.Fibrosis was staged according to the Metavir scoring system.The diagnostic performance of TE was assessed by using receiver operating characteristic(ROC) curves and the area under the ROC curve analysis.RESULTS:Two hundred and fifty-two patients met the inclusion criteria.Six(2%) patients were excluded due to unreliable TE measurements.Thus,246(171 men and 75 women) patients were analyzed.One hundred and ninety-five(79.3%) patients had chronic hepatitis C,41(16.7%) had chronic hepatitis B,and 10(4.0%) were coinfected with human immunodeficiency virus.ROC curve analysis identified optimal cut-off value of TE as high as 6.9 kPa forF ≥ 2;7.9 kPa forF ≥ 3;9.6 kPa for F = 4 in all patients(n = 246),and as high as 6.9 kPa for F ≥ 2;7.3 kPa for F ≥ 3;9.3 kPa for F = 4 in patients with hepatitis C(n = 195).Cut-off values of TE obtained by maximizing only the specificity were as high as 6.9 kPa for F ≥ 2;9.6 kPa for F ≥ 3;12.2 kPa for F = 4 in all patients(n = 246),and as high as 7.0 kPa forF ≥ 2;9.3 kPa forF ≥ 3;12.3 kPa forF = 4 in patients with hepatitis C(n = 195).CONCLUSION:The cut-off values of TE obtained in this single center study are comparable to that obtained in a recently published meta-analysis that included up to 40 studies. | Giovanna Ferraioli Carmine Tinelli Barbara Dal Bello Mabel Zicchetti Raffaella Lissandrin Gaetano Filice Carlo Filice Elisabetta Above Giorgio Barbarini Enrico Brunetti Willy Calderon Marta Di Gregorio Roberto Gulminetti Paolo Lanzarini Serena Ludovisi Laura Maiocchi Antonello Malfitano Giuseppe Michelone Lorenzo Minoli Mario Mondelli Stefano Novati Savino FA Patruno Alessandro Perretti Gianluigi Poma Paolo Sacchi Domenico Zanaboni Marco Zaramella | 2013 | World Journal of Gastroenterology2013，19，1： | 18 |
| 2 | Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma显示文摘AIM:To evaluate if indolent B cell-non Hodgkin's lymphoma(B-NHL) and diffuse large B-cell lymphoma(DLBCL) in hepatitis C virus(HCV) positive patients could have different biological and clinical characteristics requiring different management strategies.METHODS:A group of 24 HCV related B-NHL patients(11 indolent,13 DLBCL) in whom the biological and clinical characteristics were described and confronted.Patients with DLBCL were managed with the standard of care of treatment.Patients with indolent HCV-related B-NHL were managed with antiviral treatment pegylated interferon plus ribavirin and their course observed.The outcomes of the different approaches were compared.RESULTS:Patients with DLBCL had a shorter duration of HCV infection and a higher prevalence of HCV genotype 1 compared to patients with indolent B-NHL in which HCV genotype 2 was the more frequent genotype.Five of the 9 patients with indolent HCV-relatedB-NHL treated with only antiviral therapy,achieved a complete response of their onco-haematological disease(55%).Seven of the 13 DLBCL patients treated with immunochemotheraphy obtained a complete response(54%).CONCLUSION:HCV genotypes and duration of HCV infection differed between B-NHL subtypes.Indolent lymphomas can be managed with antiviral treatment,while DLBCL is not affected by the HCV infection. | Adriano M Pellicelli Massimo Marignani Valerio Zoli Mario Romano Aldo Morrone Lorenzo Nosotti Giuseppe Barbaro Antonio Picardi Umberto Vespasiani Gentilucci Daniele Remotti Cecilia D'Ambrosio Caterina Furlan Fabrizio Mecenate Ettore Mazzoni Ignazio Majolino Roberto Villani Arnaldo Andreoli Giorgio Barbarini | 2011 | World Journal of Hepatology2011，3，11： | 4 |
| 3 | HIV infection and cancer in the era of highly active antiretroviral therapy(Review)显示文摘 | Barbaro G Barbarini G | | 0，，： | 1 |
| 4 | Effect of changes in in- spired oxygen tension on indexes of oxygenation in ventilated neonates 显示文摘 | Gagliardi L Barbarini M Pugni L | 2002 | Pediatr Crit Care Meal2002，3，1： | 1 |
| 5 | Effect of changes in inspired oxygen tension on indexes of oxy- genation in ventilated neonates显示文摘 | Gagliardi L Barbarini M Pugni L | 2002 | Pediatr Crit Care Med2002，3，1： | 1 |
| 6 | Evaluation of carbapenem-resistane Enterobacteriaceae in an Italian setting:Report from the trench显示文摘 | Barbarini D Russello G Brovarone F | 2015 | Infect Genet Evol2015，30，： | 1 |
| 7 | HIV-associated coronary arteritis in a patient with fatal myocardial infarction显示文摘 | Barbaro G Barbarini G Pellicelli AM | 2001 | N Engl J Med2001，344，23： | 1 |
| 8 | Consensus interferon for chronic hepatitis C patients with genotype 1 who failed to respond to,or relapsed after,interferon-α2 b and ribavirin in combination:an Italian pilot study显示文摘 | Barbaro G Barbarini G | 2002 | Eur J Gastroenterol Hepatol2002，14，： | 1 |
| 9 | Cycloaddition of CO2 to Epoxides over both Homogeneous and Silica-supported Guanidine Catalysts显示文摘 | Barbarini A Maggi R Mazzacani A | 2003 | Tetrahedron Lett2003，44，4： | 1 |
| 10 | Use of the DiversiLab~ semiautomated repetitive-sequence-based polymerase chain reaction for epidemiologic analysis on Acinetobacter baumannii isolates in different Italian hospitals显示文摘 | CARRETTO E BARBARINI D FARINA C | 2008 | Diagnostic Microbiology and Infectious Disease2008，60，1： | 1 |
| 11 | Cycload- dition of CO2 to epoxides over both homogeneous and silica-supported guanidine catalysts 显示文摘 | Barbarini A Maggi R Mazzacani A | 2003 | Tetrahedron Lett2003，44，14： | 1 |
| 12 | Methicillin resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit:a one year survey显示文摘 | Barbarini D Fumagalli P Marone P | 2001 | Infez Med2001，9，4： | 1 |
| 13 | Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects显示文摘 | Iacobellis G Barbarini G Letizia C | 2014 | Ob- esity(Silver Spring)2014，22，2： | 1 |
| 14 | Typing of methicillin-resistant Staphylococcus aureus(MRSA)strains from and intensive care unit by random amplified polymorphic DNA(RAPD)显示文摘 | Telecco S Barbarini D Carrettoe | 1999 | New Microbiol1999，22，4： | 1 |
| 15 | Seroconversion of HB- sAg in HBeAg positive and HBeAg negative patients with chronic I-显示文摘 | d' Ettorre G Barbarini G Corti F | 2010 | Eur Rev Med Phar- macol Sci2010，14，6： | 1 |
| 16 | Boceprevir or telaprevir in hepatitis C virus chronic infection:The Italian real life experience显示文摘AIM: To check the safety and efficacy of boceprevir/telaprevir with peginterferon/ribavirin for hepatitis C virus(HCV) genotype 1 in the real-world settings. METHODS: This study was a non-randomized, observational, prospective, multicenter. This study involved 47 centers in Italy. A database was prepared for the homogenous collection of the data, was used by all of the centers for data collection, and was updated continuously. All of the patients enrolled in this study were older than 18 years of age and were diagnosed with chronic infection due to HCV genotype 1. The HCV RNA testing was performed using COBAS-Taq Man2.0(Roche, LLQ 25 IU/m L). RESULTS: All consecutively treated patients were included. Forty-seven centers enrolled 834 patients as follows: Male 64%; median age 57(range 18-78), of whom 18.3% were over 65; mean body mass index 25.6(range 16-39); genotype 1b(79.4%); diagnosis of cirrhosis(38.2%); and fibrosis F3/4(71.2%). The following drugs were used: Telaprevir(66.2%) and PEG-IFN-alpha2a(67.6%). Patients were na?ve(24.4%), relapsers(30.5%), partial responders(14.8%) and null responders(30.3%). Overall, adverse events(AEs) occurred in 617 patients(73.9%) during the treatment. Anemia was the most frequent AE(52.9% of cases), especially in cirrhotic. The therapy was stopped for 14.6% of the patients because of adverse events or virological failure(15%). Sustained virological response was achieved in 62.7% of the cases, but was 43.8% in cirrhotic patients over 65 years of age. CONCLUSION: In everyday practice, triple therapy is safe but has moderate efficacy, especially for patients over 65 years of age, with advanced fibrosis, nonresponders to peginterferon + ribavirin. | Antonio Ascione Luigi Elio Adinolfi Pietro Amoroso Angelo Andriulli Orlando Armignacco Tiziana Ascione Sergio Babudieri Giorgio Barbarini Michele Brogna Francesco Cesario Vincenzo Citro Ernesto Claar Raffaele Cozzolongo Giuseppe D’Adamo Emilio D’Amico Pellegrino Dattolo Massimo De Luca Vincenzo De Maria Massimo De Siena Giuseppe De Vita Antonio Di Giacomo Rosanna De Marco Giorgio De Stefano Giulio De Stefano Sebastiano Di Salvo Raffaele Di Sarno Nunzia Farella Laura Felicioni Basilio Fimiani Luca Fontanella Giuseppe Foti Caterina Furlan Francesca Giancotti Giancarlo Giolitto Tiziana Gravina Barbara Guerrera Roberto Gulminetti Angelo Iacobellis Michele Imparato Angelo Iodice Vincenzo Iovinella Antonio Izzi Alfonso Liberti Pietro Leo Gennaro Lettieri Ileana Luppino Aldo Marrone Ettore Mazzoni Vincenzo Messina Roberto Monarca Vincenzo Narciso Lorenzo Nosotti Adriano Maria Pellicelli Alessandro Perrella Guido Piai Antonio Picardi Paola Pierri Grazia Pietromatera Francesco Resta Luca Rinaldi Mario Romano Angelo Rossini Maurizio Russello Grazia Russo Rodolfo Sacco Vincenzo Sangiovanni Antonio Schiano Antonio Sciambra Gaetano Scifo Filomena Simeone Annarita Sullo Pierluigi Tarquini Paolo Tundo Alfredo Vallone | 2016 | World Journal of Hepatology2016，8，22： | 1 |
| 17 | Rapid virologi- cal response as a predictor of sustained response in HCV-infected patients with persistently normal ala- nine aminotransferase levels:A multicenter study显示文摘 | Puoti C Barbarini G Picardi A | 2011 | Journal of Viral Hepatitis2011，18，6： | 1 |
| 18 | Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates)显示文摘 | Piero L. Almasio Sergio Babudieri Giorgio Barbarini Maurizia Brunetto Dario Conte Pietro Dentico Giovanni B. Gaeta Claudio Leonardi Massimo Levrero Francesco Mazzotta Aldo Morrone Lorenzo Nosotti Daniele Prati Maria Rapicetta Evangelista Sagnelli Gaetano | 2010 | Digestive and Liver Disease2010，，8： | 1 |
| 19 | Catheter-related bacteremia due to Kocuria leristinae in a patient with ovarian cancer显示文摘 | Basaglia G Carretto E Barbarini D | 2002 | Clin Microbiol2002，40，： | 1 |
| 20 | Kawasaki -like syndromes and other vasculitic syndromes in HIV - infected patients 显示文摘 | Johnson RM Barbarini G Barbaro G | 2003 | AIDS2003，171，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员